NEEDLE | Jotup

Clario presents a three-part webinar series on oncology trial solutions

Retrieved on:

星期二, 十月 31, 2023

American Opportunity Tax Credit, Quality of life, FDA, Research, Safety, Clario Tech, Gait, Deep learning, EMA, Medical imaging, Medical device

PHILADELPHIA, Oct. 31, 2023 /PRNewswire/ -- Clario , a healthcare research technology company that delivers the leading endpoint technology solutions for clinical trials, announces a three-part educational webinar series on oncology trial solutions.

Key Points:

PHILADELPHIA, Oct. 31, 2023 /PRNewswire/ -- Clario , a healthcare research technology company that delivers the leading endpoint technology solutions for clinical trials, announces a three-part educational webinar series on oncology trial solutions.
Drawing from over 50 years of clinical trial expertise, Clario's webinars will focus on improving the assessment of efficacy, safety and quality of life within oncology clinical trial development programs.
Part one of the series will delve into the current advancements of AI that are enhancing the efficiency of oncology clinical trials with a focus on medical imaging.
"We are delighted to introduce Clario's new three-part educational webinar series on oncology trial solutions.

Clario presents a three-part webinar series on oncology trial solutions

Retrieved on:

星期二, 十月 31, 2023

American Opportunity Tax Credit, Quality of life, FDA, Research, Safety, Clario Tech, Gait, Deep learning, EMA, Medical imaging, Medical device

PHILADELPHIA, Oct. 31, 2023 /PRNewswire/ -- Clario , a healthcare research technology company that delivers the leading endpoint technology solutions for clinical trials, announces a three-part educational webinar series on oncology trial solutions.

Key Points:

PHILADELPHIA, Oct. 31, 2023 /PRNewswire/ -- Clario , a healthcare research technology company that delivers the leading endpoint technology solutions for clinical trials, announces a three-part educational webinar series on oncology trial solutions.
Drawing from over 50 years of clinical trial expertise, Clario's webinars will focus on improving the assessment of efficacy, safety and quality of life within oncology clinical trial development programs.
Part one of the series will delve into the current advancements of AI that are enhancing the efficiency of oncology clinical trials with a focus on medical imaging.
"We are delighted to introduce Clario's new three-part educational webinar series on oncology trial solutions.

The Boca Bearings Company has Expanded its One Way and Needle Bearing Inventory

Retrieved on:

星期四, 八月 24, 2023

HFL, Learning, Maintenance, OWC, Bearing, Agriculture, RCB, KF, CSK, FC, Temperature, RC, Car, EWC, FCB, Electric motor, Interior design, Clutch, HF

BOYNTON BEACH, Fla., Aug. 24, 2023 /PRNewswire-PRWeb/ -- We are excited to introduce you to our most popular products - Needle & One-Way Bearings. Needle bearings excel in applications that require high load capacity with a small footprint, making them essential in various industries. One-Way bearings are characterized by the function of one-way rotation and reverse stop. These are widely used in one-way clutches of washing machines, one-way clutches of automobiles, and one-way clutches of electric automatic vehicles.

Key Points:

The Boca Bearing Company has expanded its One Way and Needle Bearing Series to offer a more comprehensive size range and material offering.
Boca Bearings founder Allen Baum stated, " The Boca Bearing Company has expanded its One Way and Needle Bearing Series to offer a more comprehensive size range and material offering."
Needle bearings, also known as needle roller bearings, are a type of roller bearing with cylindrical rollers that are long and thin in comparison to their diameter.
The One Way Clutch bearings (OWC), also known as Origin One Way bearings are extra narrow and high-performance bearings available as small as a 5.4mm width.

Mattress Firm's Best Sale of the Year is Here with Unbeatable Deals for Labor Day

Retrieved on:

星期三, 八月 16, 2023

HOUSTON, Aug. 16, 2023 /PRNewswire/ -- You can rest easy with big savings on your next mattress or bedding purchase thanks to Mattress Firm, because the nation's largest mattress specialty retailer has just unveiled its Best Sale of the Year – its Labor Day sale. Struggling to fall asleep or waking up with aches and pains? Don't wait any longer to upgrade your sleep space. The right mattress and right accessories matter, that's why Mattress Firm is here to help find your perfect match at the best price now.

Key Points:

The right mattress and right accessories matter, that's why Mattress Firm is here to help find your perfect match at the best price now.
Buyers can also receive free and fast delivery with Mattress Firm's 120 Night Low Price Guarantee to ensure they get the best price possible.
Not only does Labor Day mark the end of summer, but it also marks the beginning of back-to-school season.
For more information on finding the best mattress at a reasonable price, you can visit www.mattressfirm.com/sale for additional information.

Amy Heidersbach Joins DHI Group, Inc. as Chief Marketing Officer

Retrieved on:

星期二, 六月 27, 2023

DHI Group, Inc. (NYSE: DHX) (“DHI” or “The Company”) announced today it has hired Amy Heidersbach as its new Chief Marketing Officer.

Key Points:

DHI Group, Inc. (NYSE: DHX) (“DHI” or “The Company”) announced today it has hired Amy Heidersbach as its new Chief Marketing Officer.
Based in Denver, Ms. Heidersbach will lead DHI's marketing organization, with responsibility for the Company's digital marketing strategy, product marketing, demand generation and branding for Dice, the leading technology career marketplace connecting technology professionals with employers.
Ms. Heidersbach will focus on marketing efforts to grow the number of clients and candidates on DHI’s platforms as well as increase their engagement.
And I’m excited to join the exceptional Dice and ClearanceJobs teams to help deliver market-leading innovation that enables customers to meet their talent goals and grow themselves,” said Amy Heidersbach, Chief Marketing Officer at DHI.

BNSF is Prepared for Intermodal Volume Increases Through the West Coast

Retrieved on:

星期五, 六月 16, 2023

BNSF Railway Company (BNSF) is ready for increasing intermodal volume through the West Coast ports after the International Longshore and Warehouse Union (ILWU) and the Pacific Maritime Association (PMA) announced that they reached tentative contract agreements on Wednesday.

Key Points:

BNSF Railway Company (BNSF) is ready for increasing intermodal volume through the West Coast ports after the International Longshore and Warehouse Union (ILWU) and the Pacific Maritime Association (PMA) announced that they reached tentative contract agreements on Wednesday.
These investments have increased BNSF main line track capacity by 58 miles, totaling approximately 30,000 feet for new production tracks and approximately 6,000 new parking spaces at BNSF intermodal facilities.
BNSF has also secured approximately 2,000 additional parking stalls in secondary locations around its intermodal facilities to utilize as needed to better handle volume surges.
With all the measures taken to increase network fluidity, velocity and capacity, BNSF is ready to handle the increased demand through the West Coast and meet customer service expectations.

Teleflex Announces the Arrow® EZ-IO® Needle Is Now FDA Cleared For Use in an MRI Environment

Retrieved on:

星期二, 六月 6, 2023

Medical Affairs Bureau, Emergency medicine, TFX, MRI, Patient, Corporation, Nursing care plan, FDA, Health, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, NYSE, Food, Medical imaging, Teleflex, Anesthesia

The EZ-IO® Needle, a critical component of the Arrow® EZ-IO® Intraosseous Vascular Access System, has a patented diamond tip designed for fast,1 precise and steady insertion.

Key Points:

The EZ-IO® Needle, a critical component of the Arrow® EZ-IO® Intraosseous Vascular Access System, has a patented diamond tip designed for fast,1 precise and steady insertion.
The EZ-IO® System can be used when intravenous access is difficult or impossible to obtain in emergent, urgent, or medically necessary cases.
The new labeling allows the clinician to continuously care for patients who require MRI scans without interruption to the established site for vascular access.
“We are excited to have the Arrow® EZ-IO® Needle cleared as MR Conditional and look forward to finding new ways to deliver outstanding care solutions for patients and providers.”

VacLife Pet Grooming Kit Launched on Kickstarter

Retrieved on:

星期四, 五月 11, 2023

Dual, Hair, Suction, Anxiety, Groom, Kickstarter, Kit, Dog, Pet, Blade, Cat, Petroleum jelly

FUZHOU, China, May 11, 2023 /PRNewswire/ -- VacLife Pet Grooming Kit takes Kickstarter as the launchpad today, at . The VacLife Pet Grooming Kit is an all-in-one grooming solution for pets, designed to cover all at-home grooming requirements for dogs and cats while minimizing messy cleanups. With seamless hair trimming and brushing capabilities, the kit collects 99% of pet hair in its vacuum container, making grooming a hassle-free experience for pet owners.

Key Points:

All-in-one pet grooming kit offers pet families a full range of equipment, including an AC Vacuum Cleaner, an Electric Hose, Electric Clippers, Needle, Blade, Massage Combs, and a Fur Brush
FUZHOU, China, May 11, 2023 /PRNewswire/ -- VacLife Pet Grooming Kit takes Kickstarter as the launchpad today, at .
The VacLife Pet Grooming Kit is an all-in-one grooming solution for pets, designed to cover all at-home grooming requirements for dogs and cats while minimizing messy cleanups.
With seamless hair trimming and brushing capabilities, the kit collects 99% of pet hair in its vacuum container, making grooming a hassle-free experience for pet owners.
VacLife All-In-One Pet Grooming Kit includes Multiple Accessories for Multiple Requirements:
In addition to its self-cleaning function, the VacLife Pet Grooming Kit is designed to reduce stress in pets during grooming sessions with its low-noise operation.

Cover Genius Acquires Clyde, Deepening Footprint in $121B Global Warranty Industry

Retrieved on:

星期三, 三月 15, 2023

NEW YORK, March 15, 2023 (GLOBE NEWSWIRE) -- Cover Genius, the insurtech for embedded protection, today announced it has completed an asset acquisition agreement with US-based embedded warranty provider, Clyde Technologies.

Key Points:

NEW YORK, March 15, 2023 (GLOBE NEWSWIRE) -- Cover Genius, the insurtech for embedded protection, today announced it has completed an asset acquisition agreement with US-based embedded warranty provider, Clyde Technologies.
The assets acquired will assist Cover Genius’ continued expansion into the medium-sized e-commerce segment.
Cover Genius expects there to be no impact on servicing and sales for Clyde’s partners.
Cover Genius is the insurtech for embedded protection.

ARS Pharmaceuticals Announces Presentation of Data Supporting neffy (epinephrine nasal spray) and Real-World Burden of Needle Injectors

Retrieved on:

星期四, 二月 23, 2023

SAN DIEGO, Feb. 23, 2023 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from severe allergic reactions that could lead to anaphylaxis, today announced that positive data supporting neffy® (previously referred to as ARS-1), the potential first non-injectable medicine for treatment of allergic reactions (Type I), including anaphylaxis, will be presented during the 2023 American Academy of Allergy, Asthma and Immunology (AAAAI) meeting. The meeting is being held February 24-27, 2023, in San Antonio, Texas.

Key Points:

The meeting is being held February 24-27, 2023, in San Antonio, Texas.
“We are excited to share these data from two of our primary clinical trials and the integrated analysis demonstrating the performance of neffy.
Patients indicated they would be more likely to fill a prescription for a needle-free device versus an epinephrine autoinjector.
A majority of patients indicated they would use a needle-free device instead of or before an OTC product.